Skip to main content

Table 3 The laboratory characteristics of the enrolled patients at baseline

From: Predictive value of small dense low-density lipoprotein cholesterol for cardiovascular events in Chinese elder diabetes mellitus patients

Variables Whole CVs Non-CVs Pa
(n =386) (n =92) (n = 294)
Triglycerides (mg/dL) 123.6 ± 71.3 134.5 ± 88.3 120.3 ± 63.2 0.097
LDL-C (mg/dL) 107.9 ± 30.5 116.7 ± 29.9 105.1 ± 29.8 0.001
sdLDL-C (mg/dL) 31.0± 12.1 36.2± 15.2 29.4± 16.8 0.001
HDL-C (mg/dL) 46.8± 15.1 44.2 ± 12.9 47.6 ± 15.1 0.052
Non-HDL-C (mg/dL) 129.3± 34.1 138.3±35.5 126.5± 33.4 0.004
sdLDL-C/LDL-C 0.29 ± 0.11 0.31 ± 0.13 0.28 ± 0.16 0.102
RLP-C (mg/dL) 5.0± 3.1 5.6± 3.5 4.8± 2.7 0.022
Glucose (mg/dL) 114.9 ±34.5 122.6 ±46.4 112.5 ± 29.5 0.014
HbA1c (%) 6.38 ± 1.2 6.8 ± 1.3 6.25 ±1.09 0.001
ApoA-I (mg/dL) 125.0 ± 25.3 119.3 ± 23.6 126.8 ± 27.1 0.018
ApoB (mg/dL) 86.1 ± 21.3 92.1 ± 21.6 84.2 ± 22.1 0.003
eGFR (mL/min/1.73 m2) 69.9 ± 19.2 68.8 ± 14.1 70.3± 15.6 0.411
hsCRP (mg/dL) 0.54 ± 1.1 0.53 ± 1.3 0.55 ±0.98 0.875
Lp (a) (mg/dL) 22.9 ± 24.1 25.1 ± 25.2 22.3 ±24.1 0.401
  1. Data are presented as mean mean ± SD. LDL-C: low-density lipoprotein cholesterol; sdLDL-C: small dense low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; RLP-C: remnant lipoprotein cholesterol; HbA1c: hemoglobin A1c; ApoA-I: apolipoprotein A-I; ApoB: apolipoprotein B; eGFR: estimated glomerular filtration rate; hsCRP: high-sensitivity C-reactive protein; Lp (a): lipoprotein (a)
  2. aIndicates the comparison of mean or percentage between CVs group and non-CVs group